Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen.

Purpose: H. pylori with triple-drug resistance (TR) to clarithromycin, metronidazole, and levofloxacin limits the success of rescue therapy. We aimed to identify the optimal breakpoints of antibiotic minimal inhibitory concentration (MIC) to predict the success of rescue therapy for TR H. pylori inf...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 76; no. 11; pp. 1581 - 1590
Autores principales: Hsieh, Ming-Tsung, Chang, Wei-Lun, Wu, Chung-Tai, Yang, Hsiao-Bai, Kuo, Hsin-Yu, Lin, Meng-Ying, Cheng, Hsiu-Chi, Tsai, Yu-Chin, Sheu, Bor-Shyang
Formato: research tables/charts Journal Article
Publicado: Springer Nature Nov2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146433484&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 146433484
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Nov2020
      vid: 76
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        146433484
        144448828
        146433484
        146433484
        10.1007/s00228-020-02938-5
        146433484
      ppf: 1581
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen.
      aug:
        au:
          Hsieh, Ming-Tsung
          Chang, Wei-Lun
          Wu, Chung-Tai
          Yang, Hsiao-Bai
          Kuo, Hsin-Yu
          Lin, Meng-Ying
          Cheng, Hsiu-Chi
          Tsai, Yu-Chin
          Sheu, Bor-Shyang
        affil: Department of Internal Medicine, and Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
      sug:
        subj:
          Drug Resistance, Multiple
          Helicobacter Infections Drug Therapy
          Amoxicillin Therapeutic Use
          Tetracycline Therapeutic Use
          Antibiotics Therapeutic Use
          Bismuth
          Treatment Outcomes
          Human
          Decision Making, Clinical
          Microbial Culture and Sensitivity Tests
          Breath Tests
          Urea Analysis
          Clarithromycin Therapeutic Use
          Metronidazole Therapeutic Use
          Ofloxacin Therapeutic Use
      ab: Purpose: H. pylori with triple-drug resistance (TR) to clarithromycin, metronidazole, and levofloxacin limits the success of rescue therapy. We aimed to identify the optimal breakpoints of antibiotic minimal inhibitory concentration (MIC) to predict the success of rescue therapy for TR H. pylori infection. Methods: We consecutively enrolled 430 patients with at least one course of failed H. pylori eradications to receive an H. pylori culture for antibiotic MIC test. Seventy-three (17%) had TR H. pylori infection (MIC of clarithromycin > 0.5, levofloxacin > 1, and metronidazole > 8 mg/L, respectively). Sixty-nine cases with TR H. pylori infection received rescue therapy with either ATBP (amoxicillin, tetracycline, bismuth, and PPI) or MTBP (metronidazole, tetracycline, bismuth and PPI) for 7–14 days. Fourteen patients with positive 13C-urea breath test after the first rescue therapy were retreated with a crossover second rescue therapy. Results: The MTBP regimen had higher eradication success than the ATBP regimen as the first rescue therapy for TR H. pylori (intent-to-treat (ITT) analysis, 70.3 vs. 46.9%, p = 0.048; per protocol (PP) analysis, 78.8% vs. 51.7%, p = 0.025). For MTBP regimen, tetracycline MIC ≤ 0.094 mg/L (p < 0.001) with a 14-day treatment duration (p = 0.037) could predict eradication success with 100% accuracy. For the ATBP regimen, amoxicillin MIC selected as ≤ 0.032 mg/L could optimally determine eradication success (72.2 vs. 33.3%, p = 0.025). Conclusion: Optimizing the MIC breakpoints of amoxicillin and tetracycline resistance better predicts the outcome of bismuth quadruple therapy. Further prospective studies using the revised MIC breakpoints to select antibiotics are warranted.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N